Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 29 out of 100. Risk genes beyond APOE

Topic: Amyloid, tau and blood-test diagnosis

Perspectivas futuras O mesmo princípio de modulação glial pode ser aplicado em cenários de morte clínica (parada cardiorrespiratória). Após a reanimação, a micróglia entra em estado hiperinflamatório (M1), destruindo neurônios que sobreviveram à hipoxia – a chamada "autodestruição glial". O PI-NIP poderia, em janela terapêutica crítica (~20 minutos), ser aplicado no **tronco encefálico e bulbo** para: - Preservar astrócitos e micróglia em estado M2- Realizar limpeza imunológica controlada dos tecidos- "Religar" o sistema nervoso de forma estruturada, análoga à recuperação de um computador após queda de energia Essa abordagem abre caminho para preservar a identidade neurológica do paciente em situações onde hoje a medicina só consegue manter o corpo funcionando. Disponibilidade O código-fonte e dados simulados estão disponíveis para reprodução e colaborações. Palavras-chave: Alzheimer; microglia; neuromodulação; 40Hz; 10Hz; IL-6; IL-10; TREM2; TMS multifocal; rotas alternativas; conectoma; morte clínica; reanimação; IA em saúde; preprint

Key findings

Why it matters

This preprint proposes a hypothetical precision neuro-immune protocol for Alzheimer's based on the IL-6/IL-10 ratio and 40Hz/10Hz stimulation, and discusses possible future use after cardiac arrest. It presents simulated data and future perspectives only, with no clinical results showing benefit for patients.

Study details

How this study scored 29/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 26 of the 89 points it could be judged on, which is 29 of 100. Total 29 of 100.26 of the 89 points we could judge = 29 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on journal's citation record, senior author's track record and institution's track record, so those were left out: it earned 26 of the 89 points we could judge it on, which is 29 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Zenodo (CERN European Organization for Nuclear Research))
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author Diego Damasceno holds only 1 work(s), too few to judge a track record — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration 0 / 3 OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 26 / 89 Scored on 17 of 20 parts. We have no data for the rest, so they are left out: 26 of the 89 points we could judge it on is 29 out of 100.
Total 29 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Damasceno, D. (2026). PI-NIP: Protocolo Neuro-Imune de Precisão para Alzheimer baseado em razão IL-6/IL-10 e estimulação 40Hz/10Hz. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18927138

Vancouver

Damasceno D. PI-NIP: Protocolo Neuro-Imune de Precisão para Alzheimer baseado em razão IL-6/IL-10 e estimulação 40Hz/10Hz. Zenodo (CERN European Organization for Nuclear Research). 2026. doi:10.5281/zenodo.18927138.

BibTeX

@article{damasceno2026-94fe18dd,
  author  = {Damasceno, Diego},
  title   = {{PI-NIP: Protocolo Neuro-Imune de Precisão para Alzheimer baseado em razão IL-6/IL-10 e estimulação 40Hz/10Hz}},
  journal = {Zenodo (CERN European Organization for Nuclear Research)},
  year    = {2026},
  doi     = {10.5281/zenodo.18927138},
  url     = {https://doi.org/10.5281/zenodo.18927138}
}

Related studies in Risk genes beyond APOE

Also tagged “classification”

835 studies in the library carry the topic tag “classification”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 835 tagged studies.

Similar studies

More on Risk genes beyond APOE

See all studies in Risk genes beyond APOE →